Abstract
Cardiovascular disease (CVD) in persons with diabetes has a significant and growing impact on public health. Patients diagnosed with diabetes mellitus type I or type II are highly susceptible to many heart conditions, including congestive heart failure, peripheral arterial disease, cardiomyopathy, and coronary heart disease. Diabetes demands rigorous control of all cardiovascular risk factors due to its significant risk of cardiovascular morbidity and mortality. According to estimates, the global population with diabetes will increase from 171 million in 2000 to 366 million by 2030, and the global population with hypertension will rise by 60% to reach 1.56 billion by 2025. 65–75% of deaths among diabetics are attributable to cardiovascular disease. The rationale is that cardiovascular illnesses and diabetes mellitus share a number of risk factors. The current medical system is effective in preventing infectious diseases, but it has not been effective in preventing diseases linked to a lifestyle by itself. Ayurvedic medicine is the best at managing and preventing lifestyle problems since it emphasizes a complete lifestyle adjustment for the patient. For those with diabetes and CVD, a special regimen of food (Aahar), exercise (Vihar), and herbs (Aushadhi) can help reduce symptoms and promote overall health. Reviewing the co-morbidity between diabetes mellitus (Madhumeha) and its related cardiovascular risks is the goal of this research work.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Journal of Ayurveda and Integrated Medical Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.